Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Inés Colmegna

26PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyInnate immunityPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

Sort by Publication Date:
|Sep 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.

Carrie Ye, Roko P A Nikolic, May Choi

|Sep 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.

Carrie Ye, Roko P A Nikolic, May Choi

|Aug 15, 2025
Parvovirus B19-Associated Large-Vessel Vasculitis in an Immunocompromised Patient.

Michael Aw, Todd C Lee, Arielle Mendel

|May 19, 2025
Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Using an Extended Set of Clinical Variables: An Unmet Need.

Nam Nguyen, Sasha Bernatsky, Ines Colmegna

|Apr 28, 2025
Low Dose Methotrexate Has Divergent Effects on Cycling and Resting Human Hematopoietic Stem and Progenitor Cells.

Maximilien Lora, H A Ménard, Anastasia Nijnik

|Jul 02, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort Study.

Rami Habib, Roya M Dayam, Carol Hitchon

Pageof 5

Frequent Collaborators

6 joint publications

Sasha Bernatsky

5 joint publications

Carol Hitchon

5 joint publications

Marie Hudson

4 joint publications

Glen S Hazlewood

3 joint publications

Maria A Lopez-Olivo

3 joint publications

Roko P A Nikolic

3 joint publications

Janet Pope

3 joint publications

Nancy Maltez

2 joint publications

Robin Sharma

2 joint publications

Shahin Jamal

Frequent Collaborators

6 joint publications

Sasha Bernatsky

5 joint publications

Carol Hitchon

5 joint publications

Marie Hudson

4 joint publications

Glen S Hazlewood

Top Related Videos

An <em>In Vitro</em> Approach to Photodynamic Therapy
04:53

An <em>In Vitro</em> Approach to Photodynamic Therapy

Published on : Aug 17, 2018

9.3K
An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

8.0K
See more related videos

Top Related Videos

An <em>In Vitro</em> Approach to Photodynamic Therapy
04:53

An <em>In Vitro</em> Approach to Photodynamic Therapy

Published on : Aug 17, 2018

9.3K
An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

8.0K
See more related videos